Cardiol Therapeutics Inc. - stock earnings
CRDL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.4 million USD | ? USD |
| 2023Q2 | -5.6 million USD | ? USD |
| 2023Q1 | -5.2 million USD | ? USD |
| 2022Q4 | -5.5 million USD | ? USD |
| 2022Q3 | -5.8 million USD | ? USD |
| 2022Q2 | -5.0 million USD | ? USD |
| 2022Q1 | -7.2 million USD | ? USD |
| 2021Q4 | -5.0 million USD | ? USD |
| 2021Q3 | -7.8 million USD | ? USD |
| 2021Q2 | -5.3 million USD | 63544 USD |
| 2021Q1 | -7.1 million USD | ? USD |
| 2020Q4 | -7.6 million USD | ? USD |
| 2020Q3 | -3.3 million USD | ? USD |
| 2020Q2 | -2.7 million USD | ? USD |
| 2020Q1 | -2.1 million USD | ? USD |
| 2019Q4 | -2.3 million USD | ? USD |
| 2019Q3 | -2.6 million USD | ? USD |
| 2019Q2 | -2.8 million USD | ? USD |
| 2019Q1 | -2.6 million USD | ? USD |
| 2018Q4 | -6.7 million USD | ? USD |
| 2018Q3 | -3.8 million USD | ? USD |
| 2018Q2 | -1.0 million USD | ? USD |
| 2018Q1 | -428077 USD | ? USD |
| 2017Q4 | -468302 USD | ? USD |
| 2017Q3 | -430825 USD | ? USD |
| 2017Q2 | -340693 USD | ? USD |
CRDL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.1 million USD | ? USD |
| 2022 | -22.8 million USD | ? USD |
| 2021 | -25.0 million USD | 62305 USD |
| 2020 | -16.2 million USD | 61869 USD |
| 2019 | -10.5 million USD | ? USD |
| 2018 | -11.7 million USD | ? USD |
| 2017 | -1.3 million USD | ? USD |
CRDL
Price: $1.98
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -3.37
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 88200
Market Capitalization: 125.4 million